Urinary 5-Hydroxyindoleacetic acid (5-HIAA) excretion during multiple-day high-dose chemotherapy
Authors:
- T. MuhonenTMT. Muhonen
- U.P. KarjalainenUKU.P. Karjalainen
- T. WiklundTWT. Wiklund
- 1 January 1998
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 34 (1) , 196-198
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.Journal of Clinical Oncology, 1995
- Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonistsSupportive Care in Cancer, 1994
- Delayed emesis following anticancer chemotherapySupportive Care in Cancer, 1994
- Urinary serotonin metabolite excretion during cisplatin chemotherapyCancer, 1993
- Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugsBritish Journal of Cancer, 1992
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.Journal of Clinical Oncology, 1991
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983